col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

BMJ: Open Heart
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―07 Correction: Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review
2 [GO] 2021―Jun―21 Effects of lockdown on acute coronary syndrome incidence in an area without community transmission of COVID-19 David Ferreira, Simon Graffen, Brendan Watkins, Bridie Peters, Geok Jim Lim, Harish Kamalanathan, et al. (+5)
3 [GO] 2021―Jun―14 Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19 Jacob Mok, Juan Carlos Malpartida, Kimberly O'Dell, Joshua Davis, Cuilan Gao, Harish Manyam
4 [GO] 2021―Jun―07 Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review Kamal Matli, Raymond Farah, Mario Maalouf, Nibal Chamoun, Christy Costanian, Georges Ghanem
5 [GO] 2021―Jun―04 Lockdown, slow down: impact of the COVID-19 pandemic on physical activity-an observational study Joanne Kathryn Taylor, Haarith Ndiaye, Matthew Daniels, Fozia Ahmed
6 [GO] 2021―Jun―03 Global effect of COVID-19 pandemic on the rate of acute coronary syndrome admissions: a comprehensive review of published literature Ayman Helal, Lamis Shahin, Mahmoud Abdelsalam, Mokhtar Ibrahim
7 [GO] 2021―May―17 Perception is not reality when risk stratifying adults with congenital heart disease for COVID-19 Su Yuan, Erwin Oechslin
8 [GO] 2021―Apr―21 Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts Francisco Javier Ruperti-Repilado, Daniel Tobler, Matthias Greutmann, Judith Bouchardy, Magalie Ladouceur, Laura Dos-Subira, et al. (+4)
9 [GO] 2021―Apr―20 Reintroduction of elective cardiac interventions in the era of COVID-19: the Barts experience Stephen Hamshere, Katrina Comer, Fizzah Choudhry, Krishna Rathod, Gordon Mills, Gordon Ferguson, et al. (+10)
10 [GO] 2021―Apr―19 Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors James J DiNicolantonio, Jorge Barroso-Aranda, Mark F McCarty
11 [GO] 2021―Apr―08 Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease Elena Tessitore, David Carballo, Antoine Poncet, Nils Perrin, Cedric Follonier, Benjamin Assouline, et al. (+3)
12 [GO] 2021―Apr―02 Undiagnosed SARS-CoV-2 infection and outcome in patients with acute MI and no COVID-19 symptoms Zubair Akhtar, Fahmida Chowdhury, Mohammad Abdul Aleem, Probir Kumar Ghosh, Mahmudur Rahman, Mustafizur Rahman, et al. (+7)
13 [GO] 2021―Mar―19 Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections James J DiNicolantonio, Mark McCarty, Jorge Barroso-Aranda
14 [GO] 2021―Mar―17 CT coronary angiography and COVID-19: inpatient use in acute chest pain service Michael Cronin, Peter Wheen, Richard Armstrong, Rajesh Kumar, Alannah McMahon, Max White, et al. (+4)
15 [GO] 2021―Mar―15 COVID-19 and its impact on the cardiovascular system Saud Ahmed Khawaja, Poornima Mohan, Richard Jabbour, Theodora Bampouri, Gemma Bowsher, Ahmed M M Hassan, et al. (+34)
16 [GO] 2021―Feb―07 COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction Satoshi Kitahara, Masashi Fujino, Satoshi Honda, Yasuhide Asaumi, Yu Kataoka, Fumiyuki Otsuka, et al. (+9)
17 [GO] 2021―Jan―27 Prospective multicentre cohort study of transthoracic echocardiography provision in the South West of the UK during the first wave of SARS-CoV-2 pandemic Rebecca Lucy Crook, Howell Williams, Mary Green, Stewart Brown, Richard Morris, Hannah Fletcher, et al. (+5)
18 [GO] 2020―Dec―23 Manipulation of ACE2 expression in COVID-19 Farhan Chaudhry, Sergio Lavandero, Xiang Xie, Basera Sabharwal, Ying-Ying Zheng, Ashish Correa, et al. (+2)
19 [GO] 2020―Nov―23 Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection Marco Loffi, Raffaele Piccolo, Valentina Regazzoni, Giuseppe Di Tano, Luigi Moschini, Debora Robba, et al. (+4)
20 [GO] 2020―Nov―09 Management principles in patients with COVID-19: perspectives from a growing global experience with emphasis on cardiovascular surveillance Gruschen R Veldtman, Mario Pirisi, Enrico Storti, Asad Roomi, Fadl Elmula M Fadl-Elmula, Olga Vriz, et al. (+7)
21 [GO] 2020―Nov―05 Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis Anna E Ssentongo, Paddy Ssentongo, Emily S Heilbrunn, Alain Lekoubou, Ping Du, Duanping Liao, et al. (+2)
22 [GO] 2020―Oct―26 COVID-19 pandemic and STEMI: pathway activation and outcomes from the pan-London heart attack group Callum D Little, Tushar Kotecha, Luciano Candilio, Richard J Jabbour, George B Collins, Asrar Ahmed, et al. (+14)
23 [GO] 2020―Oct―16 Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
24 [GO] 2020―Oct―05 Characteristics and outcome of patients with COVID-19 complicated by Takotsubo cardiomyopathy: case series with literature review Shruti Hegde, Rizwan Khan, Magdi Zordok, Michael Maysky
25 [GO] 2020―Sep―29 Social media in the era of COVID-19 Niti R Aggarwal, Mirvat Alasnag, Mamas A Mamas
26 [GO] 2020―Sep―16 Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management Isabella D Cooper, Catherine A P Crofts, James J DiNicolantonio, Aseem Malhotra, Bradley Elliott, Yvoni Kyriakidou, Kenneth H Brookler
27 [GO] 2020―Sep―14 Severe aortic stenosis patient risk during the COVID-19 pandemic Jasimuddin Ahamed
28 [GO] 2020―Sep―07 Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 James J DiNicolantonio, Jorge Barroso, Mark McCarty
29 [GO] 2020―Aug―27 The impact of the COVID-19 pandemic on cardiology services Omar Fersia, Sue Bryant, Rachael Nicholson, Karen McMeeken, Carolyn Brown, Brenda Donaldson, et al. (+4)
30 [GO] 2020―Aug―20 Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified? Alex Stevenson, Ali Kirresh, Samuel Conway, Laura White, Mahmood Ahmad, Callum Little
31 [GO] 2020―Jun―25 Susceptibility and prognosis of COVID-19 patients with cardiovascular disease Brian Xiangzhi Wang
32 [GO] 2020―Jun―12 COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response Paul MacDaragh Ryan, Noel Caplice
33 [GO] 2020―Jun―12 Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase James J DiNicolantonio, Mark McCarty


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.015 sec